Bayer focuses on innovation in Japan as it shifts three older drugs to Fujifilm
This article was originally published in Scrip
Executive Summary
Bayer Yakuhin, Bayer's pharmaceutical subsidiary in Japan, is transferring three older drugs to Fujifilm Pharma as part of an effort to focus on its growing portfolio of innovative products.